1 1 Research report – December 2015 Hepatitis C Barometer among GPs in Belgium.

Slides:



Advertisements
Similar presentations
Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.
Advertisements

African Americans and Hepatitis C
Title: PEOPLE LIVING WITH HIV/AIDSIN EGYPT: ROLE OF COMMUNITY PHARMACIST Authors: Nahla Maher Hegab Pharmacy graduate. Institution: College of pharmacy,
Operations Research2  The problem  With the advent of HIV and AIDS in the early 1990s, the City of New Haven instituted a needle exchange program as.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
Topic 2 The prevalence of HIV/AIDS and its potential impact on individuals, communities and countries Slide 2.1.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
Hepatitis C Rapid Antibody Testing Among At-Risk Populations, Arizona, 2014 Felicia McLean Public Health Associate Office for State, Tribal, Local and.
Hepatitis C virus epidemiology Varsha Shete Jeni
CHOLESTEROL AWARENESS PROGRAM INFORMATIVE PROGRAM.
Hepatitis C for the General Practitioner Morris Sherman MB BCh PhD FRCP(C) University of Toronto January 2013.
MDL UMC utrecht Health Strategy on HCV in The Netherlands van Hattum VHPB meeting May 2002.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Greenview Hepatitis C Fund Deborah Green Home: Cell: /31/2008.
Perinatal HIV Testing in Utah Lois Blobaum, BSN, Theresa Garrett, MSN and Nan Streeter, RN, MS Utah Department of Health.
Hepatitis C Education & Awareness. Women In Government Women In Government Foundation, Inc. is a national, non-profit, non-partisan organization of women.
1/27/20131By/ Doaa Zamel Diabetes Mellitus Type IType II 1/27/2013By/ Doaa Zamel2.
Managing Hepatitis C: An Unprecedented Correctional Healthcare Challenge ASCA/CCHA meeting Phoenix, AZ RADM Newton E. Kendig Assistant Director/Medical.
Multiple Choice Questions for discussion
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Safer Needle Devices: Protecting Health Care Workers.
Safer Needle Devices: Protecting Health Care Workers.
Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.
Public Access to Health Information. HIV/AIDS Module.
STI surveillance Belgium Results and recommandations Ruth Verbrugge WIV-ISP th STI-HIV seminar 9 th STI-HIV seminar.
W w w. h a r r i s i n t e r a c t i v e. c o m ©2007, Harris Interactive Inc. All rights reserved. Injection Impact Survey – Executive Summary Presented.
Hepatitis B - Sexually Transmitted Infection - Infects the liver and causes inflammation - About 1/3 people in the world have Hepatitis B - Can lead to.
Global summary of the AIDS epidemic December 2008 Number of people living with HIV in 2008 Total 33.4 million [31.1 million–35.8 million] Adults 31.3.
Knowledge & Attitudes about Diphtheria Vaccination in 2012 of Naresuan University Hospital’s Medical Personnel Kanyarat Jongpitakrat, Tipkamol Prajsuchanai.
2008 Minnesota HIV/AIDS Surveillance Report - Key Trends Lorraine Teel- Executive Director.
By: Megan Agren, Keriann Pfleger, and Crystal Forkey.
Module 7: Physical Health Needs Assessment. Objectives To understand the concept of harm minimisation. To be aware of the physical risks involved in drug.
HIV AIDS Africa’s Pandemic?
Hepatitis Inflammatory Disease of the Liver. Hepatitis A,B,C,…. What is Hepatitis? Inflammation of the Liver What can cause Hepatitis? * Virus – A, B,
TEMPLATE DESIGN © PRACTICE OF UNIVERSAL PRECAUTIONS AND OCCUPATIONAL EXPOSURES AMONG HEALTH CARE WORKERS Tuteja A, Chintamani,
CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.
A Pilot Intervention To Improve Injection Practices In The Informal Private Sector in Karachi, Pakistan Mubina Agboatwalla (1) Yvan Hutin (2) Steve Luby.
Blood borne Pathogens. Background  Occupational Safety and Health Administration (OSHA)  Blood borne pathogen standard developed December 6, 1991 
Blood Borne Infections AIDS & HEPATITIS B Prevention for Healthcare Workers There is others out there!
Hepatitis C in Egypt Seif Tamer Ahmed Naser. What is it? Liver disease caused by Hepatitis C virus Can range from mild illness lasting a few weeks to.
Co-infections of Hepatitis C or Tuberculosis Among Persons Living with HIV in The Florida Cohort Project Alexander Zirulnik MPH, Chukwuemeka Okafor MPH,
HIV in India David S. Hausner American Embassy School 8 th Grade Population Project 24 February 2012.
From discovery to cure in 25 years -- the Hepatitis C story Mel Krajden MD, FRCPC Medical Head, Hepatitis Acting Medical Director, Public Health Laboratory.
Hepatitis B Neha Patel, Rebecca Webber, Lilimae Martin.
2015 Mercury : 1392BE15NP Objective measure the awareness and knowledge about the Hepatitis C virus among the Belgian population transmission.
Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
INSERVICE AN INTERACTIVE JOURNEY BY NICK AND JONO.
Hepatitis A, B, and C Hepatitis A B and C  Be aware of Hepatitis A,B, or C as they are notorious for attacking the Liver, rendering it incapable of.
Itching & Scratching All About STIs.
VULNERABILITY FACTORS OF SEXUALLY TRANSMISSIBLE INFECTIONS (STIs) AMONG INJECTABLE DRUG USERS (IDUs) IN MALI Dr. BORE Djibril Oral session 3 - Abstract.
Itching & Scratching All About STIs.
By: DR.Abeer Omran Consultant pediatric infectious disease
Liver Cancer.
Government of Swaziland
Itching & Scratching All About STIs.
Reitox National Focal Point National Bureau for Drug Prevention
Itching & Scratching All About STIs.
Module 7 Communicating about CD-JEV vaccine with caregivers
Treating Hep C with Novel Agents
Dr Paul T Francis, MD Community Medicine College of Medicine, Zawia
Barometer “Save Your the Federal parliament Results
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Hepatitis B Hepatitis B is a pathogen, which causes liver disease and inflammation of the liver.
More Than Treatment.
HBV Infection: Some Sobering Facts
Module 2: HCV transmission and risk prevention
Current Threats to Public Health
Knowledge, Attitudes, and Practices Regarding Cervical Cancer and Screening Dr Ghufran Jassim MBBS,MD, MSc, PhD 8/30/2017.
2018 Global Patient Survey on Lymphomas and CLL Bulgaria.
Presentation transcript:

1 1 Research report – December 2015 Hepatitis C Barometer among GPs in Belgium

2 RESEARCH METHODOLOGY BACKGROUND & OBJECTIVES KEY FINDINGS EXECUTIVE SUMMARY 0102

3 SAMPLE DESCRIPTION DATA-COLLECTION METHOD FIELDWORK PERIOD SAMPLE SIZEQUOTA AVG. INTERVIEW DURATION minutes 7 respondents n=100CAWI FROM: 01/12/2015 TO: 21/12/2015 Regions (representative sample of Belgian general practitioners) General Practitioners in Belgium RESEARCH METHODOLOGY

4 BACKGROUND: In addition to the research among the general population and the politicians, the Save Your Liver Barometer has the purpose now to obtain insights on the knowledge of Hepatitis C among general practitioners (GP’s). OBJECTIVES: The research addressed the following topics: Incidence of hepatitis C Diagnosis of hepatitis C Prevention of hepatitis C Treatment of hepatitis C BACKGROUND & OBJECTIVES

5 KEY FINDINGS

6 Socio-demographic profile of the GP’s: Region and years of experience Sample composition is representative for the Belgian GP’s Base:Total sample (n=100) Question:S2. In which region do you work as a general practitioner? S1. How many years of experience do you have as a general practitioner? 55% 13% 32%

7 Number of patients suffering from hepatitis C Most GP’s see between 1 to 10 patients suffering from hepatitis C. In Brussel GP’s tend to see a higher number of hepatitis C patients. Base:Total sample (n=100) Question:Q1. How many of your patients are suffering from hepatitis C? TOTALFlandersBrusselsWallonia (A)(B)(C)

8 Types of hepatitis patients are tested for Most GP’s test for all 3 types of hepatitis. Higher test rates are for Hepatitis B Base:Total sample (n=100) Question:Q2. What types of hepatitis do you test your patients for? TOTAL Hepatitis A Hepatitis B Hepatitis C None of these FLANDERSBRUSSELSWALLONIA n=100n=55n=15n=32 (A)(B)(C)

9 Circumstances to test for hepatitis C – GP’s that test for hepatitis C Risky behaviour and increased level of transaminases are two main reasons for testing patients for hepatitis C, with risky behaviour being more important in Flanders and transaminases in Brussels and Wallonia. Complaints matter mainly in Brussels. Base:GP’s that test for hepatitis C (n=91) Question:Q3. Under what circumstances do you test for hepatitis C? TOTAL In case a patient asks for it after risky behaviour In case of an increased level of transaminases In case of several complaints (sleep deprivation, abdominal pain,...) *Other FLANDERSBRUSSELSWALLONIA n=91n=55n=13n=32 (A)(B)(C) A * Such as: Antecedent transfusions Body piercings/tattoos Professional (travel, work accident,…) …

10 Referral to a gastroenterologist - GP’s that test for hepatitis C Almost all GP’s refer their hepatitis C screened patients to a gastroenterologist. Few GP’s who do not refer their patients are based in Flanders. Base:GP’s that test for hepatitis C (n=91) Question:Q4. Do you send your screened patients to a gastroenterologist? TOTALFLANDERS BRUSSELSWALLONIA n=91n=55n=13n=32 (A)(B)(C)

11 Ways to prevent a hepatitis C virus infection Mainly some misunderstanding about the fact that hepatitis C virus infection can’t be prevented by thoroughly cleaning the injection material. Yet, 30% are wrong about the use of contraceptives and 20% are incorrect about use of personal razor and vaccination. Base:Total sample (n=100) Question:Q5. According to you, how can we prevent a hepatitis C virus infection? By using contraceptives By using a personal razor By using personal and sterile syringes and needles By thoroughly cleaning the injection material By vaccinating against hepatitis C TOTALFLANDERSBRUSSELSWALLONIA n=100n=55n=13n=32 (A)(B)(C)

12 Ways to prevent a hepatitis C virus infection General level of GP’s on hepatitis C is rather satisfactory with majority able to provide 3 or more correct answers to the 5 statements about prevention of a hepatitis C. 2/3 have 4 to 5 correct statements. Base:Total sample (n=100) Question:Q5. According to you, how can we prevent a hepatitis C virus infection? TOTALFlandersBrusselsWallonia (A)(B)(C) 70%73%69% 66%

13 Confusion regarding side effects of hepatitis C treatment, curability and treatment of drugs users & patients using a substitution treatment. 30% of GP’s think that you can’t get re-infected after a successful treatment for hepatitis C. Treatment of a hepatitis C virus infection Base:Total sample (n=100) Question:Q6. Are following statements about the treatment of hepatitis C correct according to you? Co-infection of HIV and hepatitis C can be treated. You can get re-infected after a successful treatment for hepatitis C. Hepatitis that is not treated can lead to liver cirrhosis with a significant risk for developing liver cancer. Hepatitis C is for 90% curable. People who use drugs or follow a substitution treatment can't be treated for hepatitis C. Treating hepatitis C has serious side effects TOTALFLANDERSBRUSSELSWALLONIA n=100n=55n=13n=32 (A)(B)(C)

14 Treatment of a hepatitis C virus infection Satisfactory understanding of treatment of hepatitis C among GP’s, although only about 15% have all statements correctly. Base:Total sample (n=100) Question:Q6. Are following statements about the treatment of hepatitis C correct according to you? TOTALFlandersBrusselsWallonia (A)(B)(C) 74%73%69% 78%

15 Treatment of a hepatitis C virus infection A significant greater amount of more experienced GP’s answer al statements correctly compared to less experienced GP’s. Base:Total sample (n=100) Question:Q6. Are following statements about the treatment of hepatitis C correct according to you? TOTALMore experiencedLess experienced (A)(B) 74% 76%72%

16 EXECUTIVE SUMMARY

17 Executive Summary - Need of information on prevention and treatment INCIDENCE: GP’s see between 1 to 10 patients suffering from hepatitis C, somewhat higher number stated in Brussels. DIAGNOSIS: Most GP’s test for all 3 types of hepatitis. Hepatitis C is tested by 9 out of 10 GP’s, with a higher test rate in Walloon region. The most common reason for testing for hepatitis C is when a patient shows a risky behaviour. However, in Brussels and Wallonia a greater number of GP’s test in case of an increased level of transaminases. Almost all GP’s send their hepatitis C screened patients to a gastroenterologist. PREVENTION: GP’s have a moderate knowledge of how to prevent a hepatitis C virus infection. Further information on material cleaning, use of contraception, use of personal razor and vaccinations is advised. TREATMENT: GP’s do not yet have a good knowledge about the new revolutionary treatments that change the face of hepatitis C treatment. Information needs concern clarity about side effects of treatment, chance of re-infection, curability and treatment of drug users & patients on a substitution treatment.

18 THANK YOU 18